Business
Press Release Aug 02 2024
Marksans Pharma Limited has informed the Exchange regarding a press release dated August 02, 2024, titled "Marksans Pharma Limited s wholly owned subsidiary in UK Relonchem Limited, receives Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets".
About this update from Marksans Pharma Limited
[{"type":"text","content":" Marksans Pharma Limited has informed the Exchange regarding a press release dated August 02, 2024, titled \"Marksans Pharma Limited s wholly owned subsidiary in UK Relonchem Limited, receives Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets\". View Attachment","length":408,"tagName":"div"}]